Abiopharma

New Form SCHEDULE 13D/A - LakeShore Biopharma Co., Ltd. Filed: 2025-08-27 AccNo: 0001213900-25-080942 Size: 43 KB

Editas Medicine to Participate in Upcoming Investor Conferences

Connect Biopharma to Present at Two Upcoming Investor Conferences in September

Penumbra, Inc. Names Shruthi Narayan as Company President

Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, delivering breakthrough image quality and FDA-cleared AI enhancements in cardiovascular ultrasound

MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells

Press Release: AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Penumbra, Inc. Names Shruthi Narayan as Company President

enGene to Participate in Upcoming Investor Conferences

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference

Avidity Biosciences to Participate in Upcoming Investor Conferences

enGene to Participate in Upcoming Investor Conferences

Cashman Steve 🟢 acquired 50.0K shares of Butterfly Network, Inc. (BFLY) at $1.64 Transaction Date: Aug 25, 2025 | Filing ID: 014953

New Form 8-K - Moleculin Biotech, Inc. Filed: 2025-08-27 AccNo: 0001437749-25-027798 Size: 239 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits